Barentz, a leading distributor of ingredients in the life science markets, is pleased to announce it has acquired a majority shareholding in Czech Republic based IMCoPharma.
- IMCoPharma is a leader in the pharmaceutical ingredients market in the CIS region and Ukraine
- Both Barentz and IMCoPharma are known for their deep technical knowledge and broad portfolio of pharmaceutical ingredients
- This strategic investment provides Barentz with the licensing capability to do business with all pharmaceutical companies in this attractive region
- IMCoPharma considers this acquisition as an opportunity for strengthening its position in this market and creating new opportunities
As a full-service pharmaceutical company IMCoPharma researches, markets and distributes a broad portfolio of quality products and services in the CIS region and Ukraine. The active pharmaceutical ingredients, excipients and final dosage forms are manufactured by leading European pharmaceutical manufacturers.
‘We are pleased with this excellent opportunity’, says Hidde van der Wal, CEO of Barentz. ‘IMCoPharma is a true leader and authority in this business segment in the CIS countries and Ukraine. This strategic investment gives us the licenses and immediate access to do business with all pharmaceutical companies in this huge region. It will certainly lead to strong synergies with our existing suppliers and portfolio of ingredients’.
Ivan Mikes, founder and CEO of IMCoPharma adds: ‘With Barentz on board we can -together with all employees - further build on our success. It will give us many new business opportunities to strengthen our position as a leader in the CIS region and Ukraine. I am convinced this is a perfect fit and we look forward to a fruitful co-operation and common growth.
IMCoPharma is a full-service pharmaceutical company that researches, markets and distributes European highest quality products to its customers in the CIS region and Ukraine
With more than 20 years’ experience of operational and technical knowledge of the local pharmaceutical markets, the company is seen as a strong and reliable partner for the CIS countries and Ukraine. The broad portfolio of services and products contains amongst others contract manufacturing, licensing, transfer of pharmaceutical technology, R&D support, assistance in marketing authorization and regulatory support. In addition to the central warehouse in Czech Republic, IMCoPharma operates licensed pharmaceutical warehouses, suitable for the storage, handling and distribution of goods in Russia (as well as other countries of the EAEU) and in Ukraine.
More information on www.imcopharma.com.
Barentz is a leading global provider of ingredients for the life sciences markets. Representing world-class suppliers, Barentz offers customers a comprehensive portfolio of speciality ingredients, including unique specialty ingredients and blends from Barentz-owned production companies, all supported by the best technical teams and application labs. Barentz Pharmaceuticals excels in supplying outstanding standard and specialized excipients, nutraceutical & functional food actives, APIs and pharmaceutical intermediates. Barentz operates in more than 60 countries, has a turnover of around 1.1 billion euros and employs over 1,100 people worldwide. To learn more, visit www.barentz.com.
For more information please contact:
Marcel Hölscher, Global Head of Marketing & Communication
email@example.com +31 (0)23 567 34 56
Saturnusstraat 15, 2132 HB Hoofddorp, The Netherlands